Home›Companies›Biotech & Pharma›RevivBio

RevivBio Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 16, 2024·Suggest an edit

About RevivBio

RevivBio is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $3,354,976 raised in two offerings on Form D since July 2022. Its chief executive is Fatemeh Mastouri.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 29, 2023Jan 16, 2024$2,954,976of $3.1M target11$268KEquityRule 506(b)Form D ↗
Jun 10, 2022Jul 5, 2022amended Oct 4, 2022$400,000of $500K target6$66,667Debt, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$3,354,976

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RevivBio's Form D filed Jan 16, 2024.

OK
KM
Karla Milcic
Director
FM
Fatemeh Mastouri
Chief Executive Officer and director

Sources

  1. SECRevivBio Inc. Form D, filed Jul 5, 2022
  2. SECRevivBio Inc. filing history